US 12,073,941 B2
Infusion device and methods
Christopher V. Reggiardo, Castro Valley, CA (US); Namvar Kiaie, Danville, CA (US); and James Thomson, Carollton, TX (US)
Assigned to Abbott Diabetes Care Inc., Alameda, CA (US)
Filed by Abbott Diabetes Care Inc., Alameda, CA (US)
Filed on Nov. 10, 2022, as Appl. No. 17/984,524.
Application 17/984,524 is a continuation of application No. 17/464,304, filed on Sep. 1, 2021, granted, now 11,508,476.
Application 17/464,304 is a continuation of application No. 17/354,343, filed on Jun. 22, 2021.
Application 17/354,343 is a continuation of application No. 16/017,480, filed on Jun. 25, 2018, granted, now 11,043,300, issued on Jun. 22, 2021.
Application 16/017,480 is a continuation of application No. 14/730,047, filed on Jun. 3, 2015, granted, now 10,007,759, issued on Jun. 26, 2018.
Application 14/730,047 is a continuation of application No. 14/042,629, filed on Sep. 30, 2013, granted, now 9,064,107, issued on Jun. 23, 2015.
Application 14/042,629 is a continuation of application No. 11/555,207, filed on Oct. 31, 2006, granted, now 8,579,853, issued on Nov. 12, 2013.
Prior Publication US 2023/0064839 A1, Mar. 2, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. G06F 21/30 (2013.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G06F 21/44 (2013.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16Z 99/00 (2019.01); H04L 9/40 (2022.01); H04W 12/08 (2021.01); A61B 5/145 (2006.01); A61M 5/315 (2006.01)
CPC G16H 40/63 (2018.01) [A61M 5/14244 (2013.01); A61M 5/14276 (2013.01); A61M 5/1723 (2013.01); G06F 21/30 (2013.01); G06F 21/44 (2013.01); G16H 20/17 (2018.01); G16H 40/67 (2018.01); G16Z 99/00 (2019.02); H04L 63/104 (2013.01); H04L 63/105 (2013.01); H04W 12/08 (2013.01); A61B 5/14532 (2013.01); A61M 5/31525 (2013.01); A61M 5/31546 (2013.01); A61M 2205/276 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3569 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A computing device in data communication with a skin-mounted assembly comprising an in vivo glucose sensor and a transmitter unit, the computing device comprising:
one or more processors;
one or more memory units operatively coupled to the one or more processors and including program instructions stored therein which, when executed by the one or more processors, causes the one or more processors to:
receive, via user input, individual hierarchical access level rights including at least first access level rights and second access level rights, wherein the first access level rights enable a first individual to view first level parameters of a plurality of parameters of the computing device, and wherein the second access level rights enable a second individual to view second level parameters of the plurality of parameters using the computing device, the second level parameters at least being different than the first level parameters, wherein the first level parameters and the second level parameters relate to data indicative of a glucose level, the data received from the skin-mounted assembly;
transmit the first access level rights to a data management system, wherein the first access level rights are associated with a first device associated with the first individual; and
transmit the second access level rights to the data management system, wherein the second access level rights are associated with a second device associated with the second individual;
receive, from the skin-mounted assembly, the data indicative of the glucose level; and
transmit the data indicative of the glucose level to the data management system,
wherein the first access level rights are configured to cause the data management system to transmit a notification including the data indicative of the glucose level to the first device.